Changes and mechanism of miRNAs in primary immune thrombocytopenia

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900027851

Enrollment

Unknown

Registered

2019-11-30

Start date

2019-12-01

Completion date

Unknown

Last updated

2019-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary Immune Thrombocytopenia

Interventions

A group of patients with ITP:None

Healthy control group:None

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. ITP patients diagnosed according to the consensus of Chinese experts on ITP diagnosis and treatment (2016 edition); 2. Aged 18-25 years.

Exclusion criteria

Exclusion criteria: 1. Abnormal platelet caused by other factors; 2. Chronic diseases, such as diabetes, high blood lipid, hypertension, etc.; 3. Treated with glucocorticoid, gamma globulin or immunosuppressant within 1 month; 4. Pregnancy, cancer or infection; 5. Combined with other autoimmune diseases, or family history of other autoimmune diseases.

Design outcomes

Primary

Measure	Time frame
microRNAs;	—

Secondary

Measure	Time frame
Platelets counts;	—

Countries

China

Contacts

Public ContactHonghui Wang

The Second Affiliated Hospital of Kunming Medical University

wanghhld@163.com+86 15198796876

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026